Drug Response Equipment
-
Manufactured by Obsidian Therapeutics, Inc.based in USA
Our proprietary cytoDRiVE® platform leverages drug responsive domains (DRDs) to control protein function using an FDA-approved small ...
-
Manufactured by Pharmigene, Inc.based in TAIWAN
PGx test is a pharmacogenomics test that predicts how patients will respond to drug therapy based on their unique genetic profile. Individuals’s genetic differences can affect different drug response (e.g. drug absorption, metabolism, or activity.) ...
-
Manufactured by CTIBiotechbased in FRANCE
Bioassay Development and toxicology screening: The cell production and differentiation expertise of CTIBIOTECH has been applied to creating unique and sensitive toxicology and drug-response bioassays in conjunction with major pharmaceutical ...
-
Manufactured by Panagene Inc.based in SOUTH KOREA
KRAS mutation is found in several cancers such as pancreatic cancer, colorectal cancer, lung cancer, biliary tract cancer and thyroid cancer. The existence of KRAS mutations is often related with a prognostic marker to drug response. For example, KRAS mutation is considered a strong prognostic marker for drug response of tyrosine ...
-
Manufactured by Panagene Inc.based in SOUTH KOREA
NRAS mutation is found in several cancers such as melanoma (13~25%), colorectal cancer (1~6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is know that the drug response against colorectal cancer medicine such as Erbitux and Cetuximab decreased and the prognosis of the metastatic colorectal cancer patient is ...
-
Manufactured by Microbiotica Limitedbased in UNITED KINGDOM
Microbiotica accesses high quality large-scale clinical datasets in order to identify microbiome-based biomarkers of drug response, drug side-effects or disease progression. The company has accessed the clinical data from academic/clinical collaborations (University of Adelaide, Cambridge University Hospitals/Cancer Research UK) or from ...
-
Manufactured by Panagene Inc.based in SOUTH KOREA
to find lung cancer in the early stage and is diagnosed as lung cancer when it is already progressed. So the prognosis tends to be bad. It is known that the patients with EGFR mutation show very high drug responses against EGFR tyrosine kinase inhibitor (TKI) such as Gefitinib (Iressa, AstraZenca) and Erlotinib (Tarceba, Roche). We expect that ...
-
based in USA
overdose cases are linked to its presence in illegal drug markets. In response to this crisis, the SAFEIife- Fentanyl (FTY) Liquid & Powder Drug Test Strip can determine if fentanyl is present in a liquid or powder, providing vital information to help with harm ...
-
Manufactured by HTG Molecular Diagnostics, Inc.based in USA
The HTG EdgeSeq Oncology Biomarker Panel (OBP) is a systems biology pathway analysis tool that profiles samples to identify therapeutic targets and drug response markers. The OBP assay utilizes our automated HTG EdgeSeq system coupled with the sensitivity and dynamic range of next-generation sequencing (NGS)-based detection, and can be ...
-
by Frontbiobased in SOUTH KOREA
-generation target anticancer drug : low target efficiency and developing resistance to treatment. 3rd-generation immune anticancer drug : low response rate of drugs, inevitable co-treatment with chemical anticancer ...
-
Manufactured by emka Technologies S.A.Sbased in FRANCE
Especially designed for mice, rats, guinea-pig and rabbits, our perfusion systems are used in pharmacological research and Toxicology, to investigate liver, kidney or mesenteric beds vascular activity and physiology, in response to drug challenges. The system provides heated, oxygenated, and nutrient-rich perfusate to the organ with or ...
-
Manufactured by C4Diagnostics SASbased in FRANCE
AST are part of the routine process of infection disease diagnosis. Once the germ responsible for an infection has been identified, a subsequent antimicrobial susceptibility test is run to determine which antimicrobial drug the germ is sensitive to. The patient then receives the appropriate antimicrobial drug, at the right ...
-
Manufactured by Microbiotica Limitedbased in UNITED KINGDOM
A fundamental challenge to any microbiome program is that human gut bacteria have been viewed as unculturable, and the microbiome of any individual could not be characterised with sufficient depth and precision to form a sound basis for translation. Thus metagenomics routinely can classify only 50 % of gut bacterial sequences, meaning that a very large fraction of gut bacteria are not seen, ...
-
Manufactured by Lexogen GmbHbased in AUSTRIA
SLAMseq is a high-sensitivity method for time-resolved measurement of newly synthesized and existing RNA in cultured cells. SLAMseq enables resolution of RNA synthesis and degradation kinetics. Lexogen offers a family of kits based on the new SLAMseq method: Thiol (SH)-Linked Alkylation for the Metabolic sequencing of RNA. SLAMseq enables the identification and quantification of newly synthesized ...
-
Manufactured by XILIS, Inc.based in USA
including xenografts and organoids, MOS offers unprecedented speed, scalability, and predictivity in a small-scale model, opening up tremendous opportunities using patient-derived micro-tumors in drug development and discovery as well as drug prioritization assays for patients. ...
-
Manufactured by GeneCentric Therapeutics, Inc.based in USA
GeneCentric has developed two gene expression profilers (LSP 210 and LSP 220) that define molecular subtypes of the two most common forms of non-small cell lung cancer (NSCLC), squamous cell carcinoma, and ...
-
Manufactured by Ncardia Services B.V.based in NETHERLANDS
Angiogenesis, the sprouting of new blood vessels from pre-existing vasculature, plays an important role in the maintenance of body homeostasis and the progression of cancer and Alzheimer’s disease, among others. Studying vessel formation can help identify and validate targets and candidates for treatment of a variety of diseases. Using Ncardia’s human iPSC-derived endothelial cells, ...
-
Manufactured by Exscientiabased in UNITED KINGDOM
In the landmark study, it was demonstrated for the first time that our functional precision-oncology platform can improve patient outcome in a prospective interventional ...
-
Manufactured by HemoShear Therapeutics, Inc.based in USA
at home as a liquid taken either orally or through a gastrostomy tube. The FDA has granted HST5040 Orphan Drug, Fast Track and Rare Pediatric Disease designations for the treatment of MMA and ...
-
based in GERMANY
MiRNAs are small, highly conserved, non-coding RNAs playing crucial roles in the regulation of virtually all aspects of living ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you